LAURUS LABS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 455.6 INR | +0.47% |
|
+3.99% | +5.74% |
| May. 15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
| Apr. 25 | Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LAURUS LABS LIMITED | Other Pharmaceuticals | +0.47% | +3.99% | +5.74% | +45.75% | +505.32% | 2.93B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- LAURUSLABS Stock
- Charts Laurus Labs Limited
- Comparison Chart
